Company Description
Stericycle, Inc., together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally.
The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
It also provides secure information destruction services, including document, hard drive, destruction services under the Shred-it brand.
The company serves healthcare businesses, including hospitals, health systems, non-affiliate hospitals, national and corporate healthcare, physician offices, surgery centers, veterinary and dental clinics, nursing and long-term care facilities, clinics and urgent care, dialysis centers, pharmacy, lab, research centers, home health organizations, etc.; and airports and seaports, education institutions, funeral homes and crematories, government and military, banks and professional services, and other businesses.
Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.
| Country | United States |
| Founded | 1989 |
| IPO Date | Aug 23, 1996 |
| Industry | Waste Management |
| Sector | Industrials |
| Employees | 13,500 |
| CEO | Ms. Cindy J. Miller |
Contact Details
Address: 2355 Waukegan Road Bannockburn, Illinois 60015 United States | |
| Phone | 847-367-5910 |
| Website | stericycle.com |
Stock Details
| Ticker Symbol | SRCL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000861878 |
| CUSIP Number | 858912108 |
| ISIN Number | US8589121081 |
| Employer ID | 36-3640402 |
| SIC Code | 4955 |
Key Executives
| Name | Position |
|---|---|
| Cindy J. Miller | President, Chief Executive Officer and Director |
| Janet H. Zelenka | Executive Vice President, Chief Financial Officer and Chief Information Officer |
| Kurt M. Rogers | Executive Vice President, General Counsel and Corporate Secretary |
| Daniel V. Ginnetti | Executive Vice President of International |
| Stephen Cory White | Executive Vice President and Chief Commercial Officer |
| Richard Joseph Hoffman | Senior Vice President and Chief Accounting Officer |
| Andrew Ellis | Vice President of Investor Relations |
| Michael S. Weisman | Executive Vice President and Chief Ethics and Compliance Officer |
| Joseph Anthony Reuter | Executive Vice President and Chief People Officer |
| Richard Michael Moore | Executive Vice President of North American Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 5, 2024 | ARS | Filing |
| Apr 5, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 5, 2024 | DEF 14A | Other definitive proxy statements |
| Feb 28, 2024 | 10-K | Annual Report |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |